EUVIMEDEUVIMED entdecken
LeitlinieOpen Access · CC BY 4.0

A practice guideline for therapeutic drug monitoring of mycophenolic acid for solid organ transplants

Shuang Liu, Hongsheng Chen, Zaiwei Song, Qi Guo, Xianglin Zhang, Bingyi Shi, Suodi Zhai, Lingli Zhang, Liyan Miao, Liyan Cui, Xiao Chen, Yalin Dong und 24 weitere

Journal of Zhejiang University-SCIENCE B · 2025-09 · 26 (9) · 897-914

DOI: 10.1631/jzus.b2400069 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Journal of Zhejiang University-SCIENCE B, online erschienen am 08.08.2025. Verfasst von Shuang Liu und 35 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China. Hauptthemen laut MEDLINE: Mycophenolic Acid, Drug Monitoring, Organ Transplantation, Immunosuppressive Agents. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the National Natural Science Foundation of China (NSFC), the Huatong Guokang Medical Research Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mycophenolic acid (MPA), the active moiety of both mycophenolate mofetil (MMF) and enteric-coated mycophenolate sodium (EC-MPS), serves as a primary immunosuppressant for maintaining solid organ transplants. Therapeutic drug monitoring (TDM) enhances treatment outcomes through tailored approaches. This study aimed to develop an evidence-based guideline for MPA TDM, facilitating its rational application in clinical settings. The guideline plan was drawn from the Institute of Medicine and World Health Organization (WHO) guidelines. Using the Delphi method, clinical questions and outcome indicators were generated. Systematic reviews, Grading of Recommendations Assessment, Development, and Evaluation (GRADE) evidence quality evaluations, expert opinions, and patient values guided evidence-based suggestions for the guideline. External reviews further refined the recommendations. The guideline for the TDM of MPA (IPGRP-2020CN099) consists of four sections and 16 recommendations encompassing target populations, monitoring strategies, dosage regimens, and influencing factors. High-risk populations, timing of TDM, area under the curve (AUC) versus trough concentration ( C 0 ), target concentration ranges, monitoring frequency, and analytical methods are addressed. Formulation-specific recommendations, initial dosage regimens, populations with unique considerations, pharmacokinetic-informed dosing, body weight factors, pharmacogenetics, and drug–drug interactions are covered. The evidence-based guideline offers a comprehensive recommendation for solid organ transplant recipients undergoing MPA therapy, promoting standardization of MPA TDM, and enhancing treatment efficacy and safety.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycophenolic AcidDrug MonitoringOrgan TransplantationImmunosuppressive AgentsHumansDelphi Technique

Stichwörter der Autor:innen

Grading of Recommendations Assessment, Development, and Evaluation (GRADE)GuidelineMycophenolic acid (MPA)Solid organ transplantTherapeutic drug monitoring (TDM)

Substanzen

Mycophenolic AcidImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Pharmacy, Peking University Third Hospital, Beijing 100191, China.
  • Department of Pharmacy, China-Japan Friendship Hospital, Beijing 100029, China.
  • Kidney Transplant Quality Control Center of National Health Commission, The 8th Medical Center of Chinese PLA General Hospital,, Beijing 100000, China.
  • Department of Pharmacy, West China Second University Hospital, Sichuan University, Chengdu 610041, China.
  • Department of Pharmacy, The First Affiliated Hospital of Soochow University, Suzhou 215006, China.
  • Department of Laboratory Medicine, Peking University Third Hospital, Beijing 100191, China.

Förderung

  • the National Natural Science Foundation of China (NSFC)
  • the Huatong Guokang Medical Research Fund

Zitieren

APA

Liu, S., Chen, H., Song, Z., Guo, Q., Zhang, X., Shi, B., Zhai, S., Zhang, L., Miao, L., Cui, L., Chen, X., Dong, Y., Ge, W., Hou, X., Jiang, L., Liu, L., Liu, L., Liu, M., Lin, T., …, & Zhao, R. (2025). A practice guideline for therapeutic drug monitoring of mycophenolic acid for solid organ transplants. Journal of Zhejiang University-SCIENCE B, 26(9), 897-914. https://doi.org/10.1631/jzus.b2400069

Vancouver

Liu S, Chen H, Song Z, Guo Q, Zhang X, Shi B, et al. A practice guideline for therapeutic drug monitoring of mycophenolic acid for solid organ transplants. Journal of Zhejiang University-SCIENCE B. 2025;26(9):897-914. doi:10.1631/jzus.b2400069

BibTeX
@article{Liu2025,
  author = {Liu, Shuang and Chen, Hongsheng and Song, Zaiwei and Guo, Qi and Zhang, Xianglin and Shi, Bingyi and Zhai, Suodi and Zhang, Lingli and Miao, Liyan and Cui, Liyan and Chen, Xiao and Dong, Yalin and Ge, Weihong and Hou, Xiaofei and Jiang, Ling and Liu, Long and Liu, Lihong and Liu, Maobai and Lin, Tao and Lu, Xiaoyang and Ma, Lulin and Wang, Changxi and Wu, Jianyong and Wang, Wei and Wang, Zhuo and Xu, Ting and Xue, Wujun and Zhang, Bikui and Zhao, Guanren and Zhang, Jun and Zhao, Limei and Zhao, Qingchun and Zhang, Xiaojian and Zhang, Yi and Zhang, Yu and Zhao, Rongsheng},
  title = {A practice guideline for therapeutic drug monitoring of mycophenolic acid for solid organ transplants},
  journal = {Journal of Zhejiang University-SCIENCE B},
  year = {2025},
  volume = {26},
  number = {9},
  pages = {897--914},
  doi = {10.1631/jzus.b2400069}
}
Kostenlos starten →